Sign Up Today and Learn More About Evolve Biosystems Stock
Invest in or calculate the value of your shares in Evolve Biosystems or other pre-IPO companies through EquityZen's platform.
Evolve Biosystems Stock (EVBI)
Evolve BioSystems is developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome.
About Evolve Biosystems Stock
Founded
2011
Headquarters
Davis, CA, US
Total Funding
69.0M
Industries
Science and Engineering, Health Care, Biotechnology
Evolve Biosystems is a spin-out from the Foods For Health Institute (FFHI) at the University of California, Davis. The company builds on more than a decade of research into the infant biome and its intimate interaction with breast milk components established by the founding scientists including Bruce German, David Mills, Carlito Lebrilla, Daniela Barile and Samara Freeman. Their fundamental research and translational clinical trials have been enabled by more than $15 million in federal and private grants since 2004.
Evolve Biosystems Press Mentions
Stay in the know about the latest news on Evolve Biosystems
Evolve Biosystems becomes Infinant Health - powerful evolution of mission, leadership, portfolio & commercialization strategy to transform the future of human health under new corporate identity
prnewswire • Oct 04, 2022
Evolve Biosystems becomes Infinant Health
biospace • Oct 03, 2022
Evolve BioSystems And The Regents Of The University Of California Jointly File Patent Infringement Complaint Against Abbott Laboratories Regarding Infant Probiotic
prnewswire • Oct 01, 2019
Evolve BioSystems digests $40m series C
Global University Venturing • Jun 14, 2018
Li Ka-Shing’s Horizon Ventures co-leads $40m round in infant probiotic firm Evolve
dealstreetasia • Jun 14, 2018
Investors in Evolve Biosystems
Discover investors in Evolve Biosystems stock and explore their portfolio companies
Evolve Biosystems Management
Leadership team at Evolve Biosystems
Director, IP & Regulatory Affairs
Samara Freeman
Co-Founder
Carlito Lebrilla
Join now and verify your accreditation status to gain access to:
- Evolve Biosystems current valuation
- Evolve Biosystems stock price
- Available deals in Evolve Biosystems and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Evolve Biosystems Stock
How to invest in Evolve Biosystems stock?
Accredited investors can buy pre-IPO stock in companies like Evolve Biosystems through EquityZen funds. These investments are made available by existing Evolve Biosystems shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Evolve Biosystems stock?
Shareholders can sell their Evolve Biosystems stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
